摘要
用酶标记免疫法测定30例突发性耳聋(突聋)患者发病期血浆血栓素B2(TXB2)和6酮前列腺素F1a(6KPGF1a)的含量,并对比不同治疗方法对血浆TXB2和6KPGF1a的影响。结果:突聋患者TXB2、TXB2/6KPGF1a(T/P)比值明显增高,6KPGF1a显著降低;阿斯匹林治疗后,TXB2及T/P比值接近正常水平,6KPGF1a无明显变化,常规治疗组各项指标均无显著性变化。提示:突聋患者可能存在T/P动态平衡失调,而对T/P平衡失调的突聋患者加用阿斯匹林治疗可能提高疗效。
Plasma concentrations of 6 keto PGF 1a and thromboxane B 2(TXB 2) were measured in 30 sudden deafness patients with enzymoimmunoassay,and the effects of different therapies on plasma levels of 6 keto PGF 1a and TXB 2 in these cases were compared.It was observed that TXB 2 and the ratio of TXB 2 to 6 keto PGF 1a (T/P) significantly increased,while 6 keto PGF 1a significantly decreased in the sudden deafness patients.TXB 2 and T/P ratio significantly decreased or tended to be normal, whereas 6 keto PGF 1a had no change after asiprin therapy.However TXB 2 and 6 keto PGF 1a and T/P ratio had no change in the conventional therapy.The study suggested that TXB 2 and 6 keto PGF 1a imbalance may play an important role in the pathogensis of sudden deafness.Aspirin therapy may improve the hearing of the sudden deafness patient with T/P ratio equilibrium.
出处
《河南医科大学学报》
1997年第1期94-96,共3页
Journal of Henan Medical University